newsfilter
← Latest News
GlobeNewswire·

RayzeBio Appoints Industry Leader Tim Van Hauwermeiren to Its Board of Directors

SAN DIEGO, Nov. 01, 2023 (GLOBE NEWSWIRE) -- RayzeBio, Inc. (NASDAQ:RYZB), a targeted radiopharmaceutical company developing an innovative pipeline against validated solid tumor targets, today announced the appointment